Wells Fargo assumed coverage of W.P. Carey with an Equal Weight rating with a price target of $63, up from $62. The entire Healthcare sector has worked in 2024 as it benefits from the secular tailwinds of the often-mentioned acceleration of retirement age individuals, occupancy recovery from COVID, and minimal-to-negative supply growth as development costs and bed moratoriums impede new stock, the firm says. Given the re-rating the space has seen and significant premiums to NAV, Wells sees growth-adjusted multiples as the best method of picking Healthcare stocks today.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WPC:
- W.P. Carey increases quarterly dividend to 87.5c per share
- W.P. Carey price target raised to $66 from $63 at Evercore ISI
- W.P. Carey price target raised to $63 from $61 at Evercore ISI
- W.P. Carey price target lowered to $60 from $61 at Scotiabank